Gyeonggi-do, South Korea

Jun-Sup Lee

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.4

ph-index = 1


Location History:

  • Gyeonggi-do, KR (2020 - 2021)
  • Yongin-si, KR (2022 - 2023)

Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jun-Sup Lee

Introduction

Jun-Sup Lee is a notable inventor based in Gyeonggi-do, South Korea. With a remarkable portfolio of four patents, he has made significant strides in the realm of pharmaceutical chemistry. His innovative research focuses on the preparation of diaminopyrimidine derivatives, which hold promise in advancing therapeutic applications.

Latest Patents

One of Jun-Sup Lee's latest patents revolves around the processes for preparing a diaminopyrimidine derivative or its acid addition salt, specifically aimed at enhancing the efficacy as a 5-HT receptor agonist. This invention not only addresses the synthesis of these derivatives but also introduces novel crystalline forms of hydrochlorides linked to the diaminopyrimidine compound. This breakthrough has implications for developing new medications that can optimize treatment options for various conditions.

Career Highlights

Currently, Jun-Sup Lee is affiliated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His role within the organization highlights his commitment to advancing medical science through innovative research and development efforts. Over the years, he has built a reputation as a dedicated and skilled inventor, contributing valuable intellectual property to the field.

Collaborations

Throughout his career, Jun-Sup Lee has collaborated with talented professionals such as Ja-Heouk Khoo and Doo-Byung Lee. These partnerships have fostered an environment of creativity and knowledge sharing that enhances the innovation process. The collaborative efforts have led to the successful development of his patented processes and formulations.

Conclusion

Jun-Sup Lee's contributions to the field of pharmaceutical development are underscored by his innovative patents and collaborative spirit. His work within Yuhan Corporation not only showcases his expertise but also reflects the potential for further advancements in therapeutic applications of diaminopyrimidine derivatives. As he continues his research, the impact of his inventions is likely to be felt within the medical community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…